Moreover, we present indications that GPC1 may possibly be associated with resistance mechanisms of alkylating agents in GBM; thus, explaining why in the downregulating panorama of this PG, GBM cells were much more susceptible to the antineoplastic agent. Here, GPC1 is linked to glioblastoma.